Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Meiji Seika's new orally active gpIIb/IIIa antagonist

March 20, 1997

Mitsui Toatsu reveals orally active antiplatelet agent

March 20, 1997

InTIME trial indicates nPA superior to tPA in MI

March 19, 1997

Aggrastat prevents heart attack, death and other complications in unstable angina

March 19, 1997

PGI2 agonists described by Fujisawa

March 19, 1997

Roberts' Agrylin approved by FDA

March 18, 1997

New clot buster comparable to t-PA in AMI

March 18, 1997

Pharmacodynamic effects of xemilofiban in cirrhotics

March 18, 1997

Taisho claims orally active antiplatelet agents

March 18, 1997

NM-702 enters phase II trials

March 14, 1997

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...